Background-Electrocardiographic QT interval prolongation is a risk factor for sudden cardiac death and drug-induced arrhythmia. The clinical correlates and heritability of QT interval duration in blacks have not been well studied despite their higher risk for sudden cardiac death compared with non-Hispanic whites. We sought to investigate potential correlates of the QT interval and estimate its heritability in the Jackson Heart Study. Methods and Results-The Jackson Heart Study comprises a sample of blacks residing in Jackson, Miss, of whom 5302 individuals with data at the baseline examination were available for study. Jackson Heart Study participants on QT-altering medications, with bundle-branch block, paced rhythm, atrial fibrillation/flutter, or other arrhythmias were excluded, resulting in a sample of 4660 individuals eligible for analyses. The relation between QT and potential covariates was tested using multivariable stepwise linear regression. Heritability was estimated using Sequential Oligogenic Linkage Analysis Routine in a subset of 1297 Jackson Heart Study participants in 292 families; the remaining sample included unrelated individuals. In stepwise multivariable linear regression analysis, covariates significantly associated with QT interval duration included R-R interval, sex, QRS duration, age, serum potassium, hypertension, body mass index, coronary heart disease, diuretic use, and Sokolow-Lyon voltage (PՅ0.01 for all). The heritability of QT interval duration in the age-, sex-, and R-R interval-adjusted model and in the fully adjusted model was 0.41 (SE, 0.07) and 0.40 (SE, 0.07; PϽ10 Ϫ11 for both), respectively. Conclusions-There is substantial heritability of adjusted QT interval in blacks, supporting the need for further investigation to identify its genetic determinants. (Circ Arrhythmia Electrophysiol. 2009;2:427-432.)
S
udden cardiac death (SCD) claims 300 000 lives annually in the United States. 1 Blacks have higher rates of SCD than whites, but the causes of the difference in event rates are unknown. [2] [3] [4] [5] Risk factors for SCD in the general population include coronary artery disease, hypertension, tobacco use, QT interval prolongation, left ventricular hypertrophy, diabetes, body mass index, and family history. 6 -9 The increased risk of SCD in blacks could result from environmental differences, including diet or smoking, from disparities in access to health care or from aggregation of multiple risk factors with strong biological underpinnings, such as increased rates of hypertension and left ventricular hypertrophy. 10 
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Family history is a consistent risk factor for SCD. 6, [11] [12] [13] Whether heritable factors contribute to the higher risk of SCD in blacks compared with whites is unknown. A common missense variant in the SCN5A sodium channel (S1102Y) found exclusively in individuals of African ancestry has been found to increase risk of ventricular arrhythmias and SCD. 14, 15 A common missense variant in the ␤ 2 -adrenergic receptor (Gln27Glu) that is more frequent in blacks has been found to increase risk of SCD in whites and had borderline significance in a small black sample. 16 Although an aggregation of many such genetic variants could contribute incrementally to differential SCD risk, existing studies of SCD in blacks and whites lack sufficient power to define the full spectrum of common and rare variants that contribute to SCD risk.
The QT interval is a reflection of myocardial depolarization and repolarization time. QT interval prolongation 17, 18 or shortening 19 is associated with increased risk of SCD in community-based samples as well as in familial congenital syndromes of long and short QT duration and ventricular arrhythmias. 20 -22 Moreover, QT interval prolongation and ventricular arrhythmia on exposure to cardiac and noncardiac medications is a life-threatening side effect and a major barrier to drug development. 23 The widespread availability of QT interval measurements in multiple cohorts makes it an attractive intermediate SCD trait and enables well-powered studies of the determinants of myocardial repolarization in the general population.
It has been shown that R-R interval-adjusted, sex-adjusted, and age-adjusted QT interval duration in community-based samples of European ancestry is heritable. 24 Heritability, quantifying the tendency of related individuals to have more similar trait values than unrelated individuals, estimates the proportion of variation in a trait that is explainable by additive genetic factors. Heritability in the Framingham Heart Study, a sample of European ancestry, has been estimated at 0.35, indicating that 35% of variation in adjusted QT interval duration is attributable to additive genetic factors. 24 Although a large-scale study by Dekker et al 18 has established several clinical correlates of QT interval duration on univariable analysis in black community-based samples, limited data on the independent correlates of QT interval duration on multivariable analysis or its heritability in blacks are currently available.
We sought to define the clinical correlates of QT interval duration in 4660 Jackson Heart Study (JHS) participants and to determine the heritability of multivariable-adjusted QT interval duration in the family-based subset of 1500 JHS participants. Demonstration that a significant proportion of multivariable-adjusted QT interval variation in blacks is attributable to genetic factors would support efforts to identify those genetic factors that could then be examined for association with SCD risk or drug-induced arrhythmias in the general population.
Methods

Study Sample
The JHS cohort includes individuals recruited from the greater Jackson, Mississippi, area, 25 some of whom were originally participants in the Atherosclerosis Risk in Communities Study (ARIC). 26 Men and women 35 to 84 years of age were included as well as family members 21 years or older who agreed to participate in the family study component, 27 with a final study cohort of 5302 participants 21 to 95 years of age. DNA samples were extracted from all JHS participants who consented to genetic studies. The pedigree data stored in the software package Progeny 2000 (www.progenygenetics.com) were checked for inconsistencies including same-sex married couples, pedigree loops, incompatible age, and ID problems. A total of 1500 individuals in 292 families had microsatellites genotyped by the Mammalian Genotyping Service (research.marshfieldclinic.org/ genetics/home/index.asp). Using microsatellite markers, pedigree relationships underwent modification to resolve Mendelian and single-marker inconsistencies. 27 Of 5302 total JHS participants in the unrelated (nϭ3802) and family (nϭ1500) components, those without informed consent (0.2%) or ECG data (0.3%), those taking digoxin (1.5%) or a QT-prolonging medication (4.8%, listed in Supplemental Table 1) , and those with left or right bundle-branch block (2.2%), atrial fibrillation or atrial flutter (0.4%), other arrhythmias (0.3%), or a pacemaker (0.2%) were excluded, resulting in the final sample of 4660 individuals who were eligible for analysis (nϭ3363 in the unrelated sample and nϭ1297 in the family sample). The total sample of 4660 individuals contributed to association analysis of clinical covariates and the related subsample of 1297 individuals in 292 families contributed to the heritability analyses. All study participants provided written informed consent, and study protocols were approved by local institutional review boards.
Clinical Characteristic Ascertainment
The baseline examination consisted of a home interview, selfadministered questionnaires, and a clinic visit. Medications taken in the prior 2 weeks were brought to clinic and transcribed verbatim with subsequent coding by a pharmacist using the Medispan dictionary (www.medispan.com/index.aspx) with classification according to the Anatomic Therapeutic Chemical Classification System (www. who.int/classifications/atcddd/en). QT-prolonging medications were annotated using the lists of medications maintained by qtdrugs.org (www.arizonacert.org/medical-pros/drug-lists/drug-lists.htm, accessed November 2006). Digoxin use, which shortens QT interval duration, was also annotated. After an overnight fast, anthropometric and seated blood pressure measurements were obtained and venipuncture was performed. Blood pressure was measured after a 5-minute rest by trained staff in the right arm of seated participants, whose back and arm were supported, using an appropriately sized cuff and a Hawksley random-zero sphygmomanometer. The average of 2 measures taken 1 minute apart was recorded. Hypertension was defined as a measured blood pressure Ն140/90 mm Hg or use of antihypertensive medication. Presence of coronary heart disease (CHD) was determined by self-reported history, physician-diagnosed or ECG-determined myocardial infarction, or self-reported angioplasty. Presence of diabetes was established by self-report or by a measured fasting glucose of Ն126 mg/dL, or use of insulin and/or oral hypoglycemic agents. Blood samples from the fasting venipuncture were analyzed for several analytes including potassium, glucose, total cholesterol, high-density lipoprotein cholesterol, and triglycerides, standardized according to the Centers for Disease Control and Prevention as previously described. 25 Low-density lipoprotein cholesterol was calculated according to the Friedewald equation. Higher alcohol use was defined as consumption of Ͼ14 drinks per week for men and Ͼ7 drinks per week for women. Four physical activity index scores, for active living, work, sport, and home and family life, were calculated based on the physical activity cohort survey administered during the home induction interview. For each index, the values ranged from 1 (low) to 5 (high). The 4 individual index values were summed to obtain the total physical activity index (range, 4 to 20). 28 
ECG Measurements
The clinical examination included supine 12-lead digital ECG using a Marquette MAC/PC digital ECG to record, store, and transmit ECG data via phone modem to the Electrocardiographic Reading Center (ECGRC) at the University of Minnesota. 25 The ECGRC used the Minnesota Code Modular ECG Analysis System (MC-MEANS) computer program for all baseline examination ECGs, which has performed well when compared with other computer algorithms and manual reads by cardiologists. 29, 30 MC-MEANS generates a representative averaged beat and determines onsets and offsets of P, QRS, and T waves simultaneously over all leads. The PR interval is the time from onset of the P wave to onset of the QRS complex. The QRS duration is the time from the onset of the Q wave to the offset of the S wave. The QT interval is the time from the onset of the Q wave to the offset of the T wave. These data are the basis for all continuous measurements and are coded using a morphology decision logic algorithm. These preliminary codes were then subjected to hierarchical exclusion rules from the Minnesota Code. Sokolow-Lyon voltage was calculated as the sum of the S-wave amplitude in lead V 1 and the greater of the R-wave amplitudes in V 5 and V 6 .
Statistical Methods
Participant baseline characteristics such as age, body mass index (BMI), systolic and diastolic blood pressures, use of antihypertensive medication, use of diuretics, hypertension, fasting glucose, fasting lipid profile (total, low-density lipoprotein, and high-density lipoprotein cholesterol and triglyceride level), serum potassium level, type 2 diabetes status, CHD status, physical activity index and QT interval, R-R interval, PR interval (lead II), and QRS duration were studied. The characteristics were summarized descriptively, in sexpooled and sex-specific analyses, using means and standard deviations for continuous parameters and using percentages for categorical parameters. Sex-specific means, standard deviations, interquartile ranges, and ranges for QT interval adjusted for heart rate using Bazett correction (QT c ) were computed. 31 Linear regression analyses were performed to identify baseline demographic and clinical characteristics associated with QT interval duration. Initially, linear regression models that included QT interval duration as the dependent variable and a clinical characteristic along with 3 concomitant variables (age, sex, and R-R interval) as independent factors were used to explore the relationship of each clinical characteristic individually with QT interval duration. Factors that were statistically significant (PϽ0.05) in these models were selected for stepwise model building. A separate analysis of systolic and diastolic blood pressure, hypertension status, and use of antihypertensive medications, all of which individually were significant in the age-adjusted, sex-adjusted, and R-R-adjusted analysis, was conducted using a linear regression model with stepwise selection, after forcing in age, sex, and R-R interval. Based on the model R 2 statistic and Mallows C p statistic, only hypertension status was chosen for inclusion in the final model as the predictor of QT interval with the greatest explanatory power among blood pressure-related factors. All factors identified for the final model selection were then tested using a multivariable linear regression model with stepwise backward elimination and retention of variables, with PϽ0.05 in the final model.
Finally, 2 linear regression models were examined to obtain heritability estimates for the sample. The first model included only age, sex, and R-R interval (model 1); age, sex, R-R interval, and all additional factors with PϽ0.05 in the multivariable model were included in the second model (model 2). Heritability analyses in either model were restricted to the 1297 participants in 292 families with complete information for all characteristics in model 2 to allow comparison. The values of the standardized adjusted residuals, Winsorized at 3 standard deviations, obtained from the 2 models, were analyzed using variance components methods implemented in Sequential Oligogenic Linkage Analysis Routine, which parses genetic and nongenetic components of variation in a trait, to estimate heritability. 32 
Results
Baseline characteristics after exclusion of individuals taking QT-altering medications or with left or right bundle-branch block, arrhythmia, or paced rhythm are presented in Table 1 . The sample population was obese on average, with mean BMI of 31.7 kg/m 2 and had a high prevalence of hypertension (60%), diabetes (17%), and CHD (5.6%). The mean QT interval was longer in women (416.5 ms; SD, 30.6) compared with men (407.4 ms; SD, 30.0; P for differenceϽ0.0001) as expected. The mean R-R interval was 981 ms (SD, 159) in men and 942 (148) in women. We compared the heart rate-adjusted QT interval in the 4660 men and women not taking any QT-altering medications with that in the 223 individuals taking QT-prolonging medications and in the 45 individuals taking digoxin, known to shorten QT interval duration. Men who were not taking any QT-altering medication had a QT c of 413.1 ms (SD, 25.3), compared with 422.7 ms (SD, 25.3; P for differenceϭ0.008) for men on QTprolonging medication and 412.3 ms for men on digoxin (SD, 31.5; P for comparison to group on no QT-altering medicationϭ0.90). Women not taking any QT-altering medication had a QT c of 430.8 ms (SD, 24.0), compared with 440.9 ms (SD, 25.4; PϽ0.0001) for women taking QT-prolonging medication and 406.9 ms (SD, 33.8; PϽ0.0001) for women taking digoxin.
In the initial linear regression analyses (adjusting only for age, sex, and R-R interval), the following factors were significant predictors of QT interval duration (PϽ0.05) when added individually: QRS duration, PR interval, hypertension, systolic blood pressure, diastolic blood pressure, antihypertensive medication, diuretic use, Sokolow-Lyon voltage, BMI, current smoking, physical activity index, prevalent CHD, and serum potassium ( Table 2 ). In a stepwise linear regression analysis of hypertension status, systolic and diastolic blood pressures, and antihypertensive use, hypertension status entered into the model first and explained the greatest proportion of variation in QT interval duration compared with the other 3 variables and was thus used in subsequent analyses for ease of interpretation (data not shown). In the Values for continuous traits are mean (standard deviation) and for categorical traits are percentages in all JHS participants after exclusions for use of QT-prolonging medication or digoxin, bundle-branch block, atrial fibrillation of flutter, other arrhythmias, or pacemaker. QT c represents Bazett correction for heart rate (QT c ϭQT/sqrt͓RR͔). HDL indicates high-density lipoprotein; NA, not applicable.
backward stepwise multivariable linear regression analysis, the following factors were independently positively associated (PϽ0.05) with increase in QT interval duration: R-R interval, female sex, QRS duration, age, hypertension, BMI, CHD status, diuretic use, and Sokolow-Lyon voltage (Table  3) . Serum potassium was negatively associated with QT interval duration (PϽ0.0001). The majority of variation in QT interval duration was explained by R-R interval (47%), female sex (5%), QRS duration (3%), and age (2%). All other factors explained less than 1% of variation in QT interval duration. The correlation of residuals from the age-adjusted, sex-adjusted and R-R interval-adjusted model (54% variation explained) and those from the fully adjusted model (58% variation explained) was 0.99.
The estimated heritability of R-R interval-, sex-, and ageadjusted QT interval residuals was 0.40 (SE, 0.07; PϽ10
Ϫ11
) and for residuals from the fully adjusted model shown in Table  3 was 0.41 (SE, 0.07; PϽ10
; Table 4 ).
Discussion
In this study, several independent clinical correlates of QT interval duration in a large black community-based sample were identified and were consistent with several correlates previously reported in the literature. It was demonstrated for the first time that adjusted QT interval duration was a heritable trait with a substantial proportion of variation explained by additive genetic factors in blacks.
QT interval duration was found to be positively associated with R-R interval, female sex, QRS duration, age, hypertension, BMI, CHD, use of diuretics, and Sokolow-Lyon voltage and negatively associated with serum potassium. These observations were consistent with findings reported by Dekker et al 18 in whites and blacks from the Atherosclerosis Risk in Communities study that increasing QT c quintiles showed significant trends for increasing age, hypertension prevalence, and BMI and decreasing serum potassium on adjustment for age, sex, and race when these factors were considered individually. No significant associations of triglycerides, total cholesterol, high-density lipoprotein cholesterol, or diabetes with QT interval was found in JHS regression models adjusted for age, sex, and R-R interval but were found by Dekker et al. This could reflect chance differences between JHS and ARIC cohorts or reduced power in the JHS sample because of the smaller total sample size. The 2 studies included only 1601 individuals in common who were examined between 1987 and 1989 in ARIC and between 2000 and 2004 in the JHS. Alternatively, some of the associations in the analyses by Dekker et al could have been driven by effects in the white component of the ARIC cohort in the raceadjusted analyses reported in the combined sample.
In the JHS, there was a strong association of increasing QT interval with diuretic use and with decreasing serum potassium. It would be expected that diuretic use might be associated with QT interval duration in a community-based sample because of its relationship with total body potassium loss. The observation that serum potassium and diuretic use were independently significant in the same model could reflect the known impact of diuretic-induced hypomagnesemia on QT interval duration, 33 or the incomplete corre- Each of these characteristics was significantly associated with QT duration (PϽ0.05) in a linear regression model including age, sex, R-R, and the parameter of interest as independent variables. Shown are the model R 2 interpretable as the percent of QT interval variability explained by clinical covariates in linear regression in JHS participants including R-R interval, sex, and age (model 1) and R-R interval, sex, QRS duration, age, serum potassium, hypertension, BMI, CHD status, diuretic use, and Sokolow-Lyon voltage (model 2). The heritability was estimated in 1297 JHS participants in 292 families using variance components methods implemented in SOLAR 32 and represents the fraction of remaining QT interval variation (after adjustment for covariates) explained by additive genetic factors.
lation between 1-time serum potassium measures and total body potassium stores.
Prospective studies have shown that QT interval duration is predictive of incident CHD, even after adjustment for known CHD risk factors in individuals of African or of European ancestry. 18, 34, 35 In the JHS, the QT interval was shown to be positively associated with prevalent CHD, which could be due to an intrinsic predictive nature of adjusted QT interval on incident CHD or some reflection of acquired derangements of depolarization or repolarization that follow the development of CHD or aggregation of its risk factors.
In addition, a positive association was found between QT interval duration and increasing Sokolow-Lyon voltage, an ECG correlate of left ventricular mass. Left ventricular hypertrophy, measured by ECG or echocardiography, has been associated with QRS lengthening (presumably from myocardial hypertrophy and fibrosis) and QT prolongation in hypertensive subjects. 36, 37 It is important to note that the large sample size of more than 4000 individuals means that even clinically insignificant effects on QT interval duration can reach strong statistical significance. The partial R 2 , reflecting the fraction of variation explained by a clinical factor, was 0.47 for R-R interval, 0.05 for female sex, 0.03 for QRS, and 0.02 for age. All other covariates explain less than 1% of variation in QT interval and thus contribute little to the regression model; these could easily be dropped from analyses without altering results substantially. Because the QRS duration is a subcomponent of the QT interval, it may not be appropriate to adjust for it, and most studies do not.
There is evidence that a substantial fraction of QT interval variability after adjustment for known covariates is explained by additive heritable factors in European-derived samples. The finding that 40% to 41% of variation in adjusted QT interval in blacks is attributable to genetic factors is consistent with previous reports in individuals of European ancestry in the Framingham Heart Study (35%) and in the Family Heart Study (34%). 24, 38 It is important to establish that a heritable basis for a complex trait such as QT interval duration exists before embarking on genetic studies. Because of the known influences of diurnal variability, effects of adrenergic stimulation and measurement error on QT interval measures, it is certainly possible that an even greater proportion of the biologically meaningful component of QT interval variation is explained by genetic factors.
Strengths of the current report include the large sample size, the broad range of precisely measured covariates, the simultaneous adjustment for multiple risk factors, and the availability of a family component to allow estimation of heritability of QT interval in blacks. Limitations to the study must be acknowledged. The power to detect any true underlying association of a factor with QT interval is a function of both the strength of effect and the prevalence of the factor. Thus, the failure to find association of higher alcohol use or diabetes could be due to limited power. Last, QT interval measurements are limited by ambiguity of the T-wave offset and different computer algorithms can define this differently. However, the same well-validated computer algorithm was applied to the entire sample and any imprecision in T-wave offset would be expected to add noise to the QT interval trait and only bias association findings to the null.
Given the well-supported relationship of QT interval prolongation with SCD in the general population, the high rates of SCD in black populations and the substantial heritability of QT interval duration in the JHS, efforts to define the genetic basis of QT interval variation in populations of African ancestry are warranted. The availability of DNA in the large, community-based JHS sampled without regard to phenotype 27 will enable large-scale tests for association, admixture mapping, 39 and linkage to identify the genetic variants that underlie the heritable component of myocardial repolarization in people of African ancestry. Given the recent successes in identifying common variants that influence QT interval duration in European-derived samples, 40 it is reasonable to expect that such variants will be operative in African-derived samples as supported by a recent report in 1497 non-Hispanic blacks. 41 Whether such variants contribute to risk for SCD or drug-induced arrhythmias will require further work in this and other cohorts.
CLINICAL PERSPECTIVE
Electrocardiographic QT interval prolongation is a risk factor for sudden cardiac death and drug-induced arrhythmia. The clinical correlates and heritability of QT interval duration in blacks have not been well studied despite their higher risk for sudden cardiac death compared with non-Hispanic whites. We sought to investigate potential correlates of the QT interval and estimate its heritability in the Jackson Heart Study, including 4660 individuals free of exclusions. We found that the following clinical factors were independently related to increasing QT interval duration: female sex, increasing R-R interval, QRS duration, body mass index, and Sokolow-Lyon voltage; decreasing serum potassium; and presence of hypertension, coronary heart disease, and diuretic use. We found that 40% to 41% of adjusted QT interval duration is attributable to genetic factors. These findings suggest that there is merit to studying genetic variants in blacks for their influence on QT interval duration. Genetic factors that influence QT interval duration would be strong candidates to influence drug-induced arrhythmias and sudden cardiac death and could improve our prediction of adverse cardiovascular outcomes.
